These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12559287)

  • 1. Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy.
    Elshaikh MA; Angermeier K; Ulchaker JC; Klein EA; Chidel MA; Mahoney S; Wilkinson DA; Reddy CA; Ciezki JP
    Urology; 2003 Jan; 61(1):152-5. PubMed ID: 12559287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapy.
    Roeloffzen EM; Battermann JJ; van Deursen MJ; Monninkhof EM; Visscher MI; Moerland MA; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1072-9. PubMed ID: 20615621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds.
    Sugawara A; Nakashima J; Kunieda E; Nagata H; Asakura H; Oya M; Shigematsu N
    Radiat Oncol; 2010 Sep; 5():86. PubMed ID: 20875137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
    Crook J; McLean M; Yeung I; Williams T; Lockwood G
    Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy.
    Lee N; Wuu CS; Brody R; Laguna JL; Katz AE; Bagiella E; Ennis RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1457-60. PubMed ID: 11121648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer.
    Morris WJ; Keyes M; Palma D; McKenzie M; Spadinger I; Agranovich A; Pickles T; Liu M; Kwan W; Wu J; Lapointe V; Berthelet E; Pai H; Harrison R; Kwa W; Bucci J; Racz V; Woods R
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1432-8. PubMed ID: 19036530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T
    Jpn J Clin Oncol; 2006 May; 36(5):285-9. PubMed ID: 16698803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication.
    Chira C; Delouya G; Larrivée S; Carrier JF; Taussky D
    Radiat Oncol; 2013 Jul; 8():177. PubMed ID: 23837971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy.
    Crook J; Toi A; McLean M; Pond G
    Brachytherapy; 2002; 1(3):131-7. PubMed ID: 15090275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
    Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Takeda A; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
    Keio J Med; 2012; 61(3):89-94. PubMed ID: 23018491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is intraoperative nomogram-based overplanning of prostate implants necessary?
    D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dependence of prostate postimplant dosimetric quality on CT volume determination.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1111-7. PubMed ID: 10421545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of various dosimetric quality indicators in prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):717-24. PubMed ID: 10348304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of urinary retention following prostate brachytherapy.
    Bucci J; Morris WJ; Keyes M; Spadinger I; Sidhu S; Moravan V
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):91-8. PubMed ID: 12007946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study.
    Locke J; Ellis W; Wallner K; Cavanagh W; Blasko J
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):712-9. PubMed ID: 11849794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
    Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.